Microelectromechanical Organs-on-Chip
Max Mastrangeli (TU Delft - Electronic Components, Technology and Materials)
H. Aydogmus (TU Delft - Electronic Components, Technology and Materials)
M. Dostanic (TU Delft - Electronic Components, Technology and Materials)
P.A. Motreuil-Ragot (TU Delft - Electronic Components, Technology and Materials)
Nele Revyn (TU Delft - Electronic Components, Technology and Materials)
B. de Wagenaar (TU Delft - Electronic Components, Technology and Materials)
Ronald Dekker (TU Delft - Electronic Components, Technology and Materials)
PM Sarro (TU Delft - Electronic Components, Technology and Materials)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Stemming from the convergence of tissue engineering and microfluidics, organ-on-chip (OoC) technology can reproduce in vivo-like dynamic microphysiological environments for tissues in vitro. The possibility afforded by OoC devices of realistic recapitulation of tissue and organ (patho)physiology may hold the key to bridge the current translational gap in drug development, and possibly foster personalized medicine. Here we underline the biotechnological convergence at the root of OoC technology, and outline research tracks under development in our group at TU Delft along two main directions: fabrication of innovative microelectromechanical OoC devices, integrating stimulation and sensing of tissue activity, and their embedding within advanced platforms for pre-clinical research. We conclude with remarks on the role of open technology platforms for the broader establishment of OoC technology in pre-clinical research and drug development.